会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 72. 发明公开
    • NEOVASCULARIZATION INHIBITOR
    • 抑制剂DER NEOVASKULARISATION
    • EP0821961A1
    • 1998-02-04
    • EP96910205.2
    • 1996-04-19
    • NIPPON SHINYAKU COMPANY, LIMITED
    • UEDA, FusaoKATOH, Fumitaka
    • A61K31/53
    • A61K31/53
    • The invention relates to a neovascularization inhibitor composition comprising a compound of the following general formula [I] or a salt thereof, or a solvate thereof, as an active ingredient,
      wherein R 1 represents hydrogen, optionally substituted alkyl, aralkyl, arylalkenyl, or aryl; R 2 represents optionally substituted alkyl, aralkyl, arylalkenyl, or aryl; or R 1 and R 2 conjoinedly and taken together with the adjacent N atom, i.e. in the form of NR 1 R 2 , represent a 4- through 8-membered cyclic amino group optionally containing nitrogen, oxygen, or sulfur as a ring member in addition to said N atom and optionally being further substituted.
    • 本发明涉及一种新生血管形成抑制剂组合物,其包含作为活性成分的下列通式ⅪI或其盐或其溶剂化物的化合物:其中R 1表示氢,任选取代的烷基,芳烷基,芳基烯基 ,或芳基; R 2表示任选取代的烷基,芳烷基,芳基烯基或芳基; 或R 1和R 2连接并与相邻的N原子一起,即以NR 1 R 2的形式,代表任选含有氮,氧的4-至8-元环氨基 ,或除了所述N原子之外的硫作为环成员,并且任选地被进一步取代。
    • 78. 发明公开
    • FAT EMULSION
    • FETTEMULSION。
    • EP0598116A1
    • 1994-05-25
    • EP90917270.2
    • 1990-11-26
    • NIPPON SHINYAKU COMPANY, LIMITED
    • SEKI, JunzoUSHIMARU, KouichiSUGIYAMA, Makoto
    • A61K9/107A61K31/71
    • A61K9/1075A61K31/7048
    • A fat emulsion developed to solve the problems of polyene antifungal antibiotics that they have such a severe toxicity as to limit the administration range thereof by suitably designing the administration form, thereby reducing the hemolytic toxicity and nephrotoxicity and facilitating the migration of a drug toward infected parts without adversely affecting the pharmacological action (antifungal action) on a molecular level. The emulsion comprises 0.005 to 5 % of a polyene antifungal antibiotic, 0.5 to 30 % of a simple lipid, and a phospholipid in an amount 0.15 to 2 times as large as that of the simple lipid, wherein the relative proportion of each ingredient is controlled to give a fine microemulsion of a mean particle diameter of at least 10 nm up to 100 nm. This emulsion can remarkably enhance the efficacy of polyene antifungal antibiotics such as Amphotericin B and is very useful for the development of medicines.
    • 为了解决多烯抗真菌抗生素的问题,开发了一种脂肪乳剂,它们具有如此严重的毒性,通过适当地设计给药形式来限制其给药范围,从而降低溶血毒性和肾毒性并促进药物向感染部位的迁移 而不会对分子水平的药理作用(抗真菌作用)产生不利影响。 乳液含有0.005〜5%的多烯抗真菌抗生素,0.5〜30%的单一脂质,磷脂的量为单质脂质量的0.15〜2倍,其中各成分的相对比例被控制 得到至少10nm至100nm的平均粒径的微细微乳液。 该乳液可以显着提高多烯抗真菌抗生素如两性霉素B的功效,对于药物的开发是非常有用的。